Abstract Many (> 40%) women discontinue antidepressants during pregnancy because of
concerns about effects on the foetus, based on information from inadequately-controlled …

Pharmacological treatment of any maternal illness during pregnancy warrants consideration
of the consequences of the illness and/or medication for both the mother and unborn child …

Background: Antidepressant use during pregnancy and the peripartum period is common
despite the absence of clear evidence-based guidelines to direct clinical use of these …

Introduction: The prevalence of depression in pregnancy is over 10% and a significant
proportion of pregnant women use antidepressant medication. The safety of antidepressants …

The relative safety of antidepressants during pregnancy has received substantial attention,
but most syntheses fail to account for mental illness effects. We aimed to evaluate the …

Objective: The American College of Obstetricians and Gynecologists and the American
Psychiatric Association both recommend pharmacotherapy for perinatal depression when …

OBJECTIVE: The purpose of this study was to quantify the rate of exposures to
antidepressants during pregnancy in a large cohort of women. STUDY DESIGN: This was a …

Importance Prenatal antidepressant exposure has been associated with adverse outcomes.
Previous studies, however, may not have adequately accounted for confounding. Objective …

Importance Antidepressants are commonly used during pregnancy, but limited information is
available about individual antidepressants and specific birth defect risks. Objective To …

This article reviewed the results of 21 recent meta‐analyses examining the relationship
between maternal use of antidepressants during pregnancy and negative outcomes in …